Showing posts with label Migraine. Show all posts
Showing posts with label Migraine. Show all posts

Wednesday, 21 November 2018

PharmaPoint: Migraine - Global Drug Forecast and Market Analysis to 2026

Researchmoz added Most up-to-date research on "PharmaPoint: Migraine - Global Drug Forecast and Market Analysis to 2026" to its huge collection of research reports. An insight on the important factors and trends influencing the market.
Migraine is a complex neurological condition, characterized by frequent headaches that can last between four and 72 hours. The pain is often unilateral and pulsating in nature, which can often be worsened by physical activity. In most cases, migraine is associated with symptoms such as photophobia, phonophobia, osmophobia, nausea, vomiting, loss of appetite, and sometimes sensory disturbances. The market is currently split into acute and preventative segments, with the majority of drugs used in treatment genericized across the 7MM (US, France, Germany, Italy, Spain, UK, Japan). The current migraine treatment landscape is mainly dominated by generic drugs, as the majority of migraine drugs have seen their patents expire. Pharmacological treatment is commonly segmented into two groups, acute (abortive) and preventative (prophylaxis) treatment.

Get a Sample PDF at: https://www.researchmoz.us/enquiry.php?type=S&repid=1375918

GlobalData estimates that drug sales for migraine in 2016 were approximately $3.3 billion across the seven major markets covered in this report. Over the 10-year forecast period, the market is expected to grow to $8.7 billion at a CAGR of 10.3%. This growth will be driven by the launch of seven late-stage pipeline products. These seven drugs can be split into three classes; CGRP monoclonal antibodies, gepants and ditans, which all have a novel mechanism of action and are expected to address significant unmet needs in the migraine market.

Scope

- Overview of migraine, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and disease management.
- Annualized migraine therapeutics market revenue, cost of therapy per patient, and treatment usage patterns in two patient segments (episodic, chronic), forecast from 2016 to 2026.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the migraine therapeutics market
- Pipeline analysis: comprehensive data assessing emerging trends and mechanisms of action under development for migraine therapy. The most promising candidates in Phase III development are profiled.
- Analysis of the current and future market competition in the global migraine therapeutics market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

The report will enable you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global migraine therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global migraine therapeutics market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/pharmapoint-migraine-global-drug-forecast-and-market-analysis-to-2026-report.html/toc

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfil all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organisations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us

For More Reports Visit @ http://marketresearchlatestreports.blogspot.com/

Monday, 16 April 2018

Global Migraine Market: Industry Analysis & Outlook (2017-2021) | Now Available at Researchmoz.us

Researchmoz added Most up-to-date research on "Global Migraine Market: Industry Analysis & Outlook (2017-2021)" to its huge collection of research reports.

Migraine is a chronic neurovascular disorder characterized by severe recurrent headaches. It is one of the most common and most prevalent disabling neurological conditions, characterized by episodes often called migraine attacks. They are quite different from regular headaches which are non-migrainous. Migraineurs generally have a lower threshold to triggers that might cause neuronal hyperexcitability, including sleep disturbances, environmental or emotional challenges, alcohol exposure, diet, and hormonal cycles/changes, among others. Migraine attacks can cause significant pain for hours to days and can be so severe that the pain is disabling. Migraine headache is typically throbbing, unilateral (one sided), and is aggravated by physical activity. It typically presents with additional symptoms in addition to headache pain, including nausea, and sensitivity to light and/or sound.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1129609

Depending on symptoms, migraine is broadly classified into two categories, Chronic and Episodic. Migraines can be treated with two types of drugs: abortive and preventive. Abortive medications are especially useful for people who have nausea or vomiting related to their migraine, and they work quickly. Preventive treatment is considered if migraine occurs frequently, typically more than one migraine per week, or if migraine symptoms are severe.

The global migraine market is set to experience favourable growth driven by factors such as increasing female population & increasing cigarette consumption. Further, the scope of growth for this market will be broadened by rising healthcare expenditure and accelerating economic growth. However, growth of this budding market will be hindered by limitations of current migraine therapies, regulatory challenges and high cost associated with migraine drugs.

The report “Global Migraine Market: Industry Analysis & Outlook (2017-2021)” analyses the development of this market, with focus majorly on the U.S. market. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Amgen Inc., Eli Lilly and Company, Teva Pharmaceuticals & Alder Biopharmaceuticals are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global migraine market along with the study of the regional markets.

Table of Content

1. Overview
1.1 Introduction
1.2 Stages
1.3 Diagnosis
1.4 Treatment

2. Global Market Analysis
2.1 Global Migraine Market by Value
2.2 Global Migraine Market Forecast by Value
2.3 Global Migraine Market by Drug Type
2.4 Global Therapeutic Botulinum Toxin Market Forecast by Value
2.5 Global Therapeutic Botulinum Toxin Market by Indication

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/global-migraine-market-industry-analysis-outlook-20172021-report.html/toc

3. Regional Market
3.1 The U.S.
3.1.1 The U.S. Total Migraine Population
3.1.2 The U.S. Diagnosed & Treated Adult Migraine Population
3.1.3 The U.S. Migraine Population with CV Risk Factors
3.1.4 The U.S. Migraine Treatment by Specialty
3.1.5 The U.S. Migraine Treated Population by Drug Type
3.1.6 The U.S. Acute Migraine Prescription Volume
3.2 The U.S Migraine Drugs Revenue
3.2.1 The U.S. Cambia Drug Revenue
3.2.2 The U.S. Lasmiditan Drug Revenue & Treated Patients
3.2.3 The U.S. Alder Drug Revenue
3.3 Europe
3.3.1 Europe Total Migraine and Diagnosed Population
3.4 Europe Migraine Drug Revenue
3.4.1 Europe Alder Drug Revenue

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Growing Female Population
4.1.2 Increasing Cigarette Consumption
4.1.3 Rising HealthCare Expenditure
4.1.4 Accelerating Economic Growth
4.1.5 Increasing Prevalence of Headache Disorder
4.2 Key Trends & Development
4.2.1 Drugs Under Pipeline for Migraine
4.2.2 Technological Advancements
4.2.3 Increasing Awareness for Migraine
4.3 Challenges
4.3.1 Limitations of Current Migraine Therapies
4.3.2 Regulatory Challenges
4.3.3 High Cost Associated

5. Competition
5.1 Global Market
5.1.1 Global Migraine Market- Revenue Comparison of Key Companies
5.1.2 Global Migraine Market- Market Cap Comparison of Key Companies

Continue...

Sunday, 11 February 2018

Migraine Market 2017 - Global Industry size, Shares, Trends, Growth, Analysis and Forecast 2021

Researchmoz added Most up-to-date research on "Global Migraine Market: Industry Analysis & Outlook (2017-2021)" to its huge collection of research reports.

Migraine is a chronic neurovascular disorder characterized by severe recurrent headaches. It is one of the most common and most prevalent disabling neurological conditions, characterized by episodes often called migraine attacks. They are quite different from regular headaches which are non-migrainous. Migraineurs generally have a lower threshold to triggers that might cause neuronal hyperexcitability, including sleep disturbances, environmental or emotional challenges, alcohol exposure, diet, and hormonal cycles/changes, among others. Migraine attacks can cause significant pain for hours to days and can be so severe that the pain is disabling. Migraine headache is typically throbbing, unilateral (one sided), and is aggravated by physical activity. It typically presents with additional symptoms in addition to headache pain, including nausea, and sensitivity to light and/or sound.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1129609

Depending on symptoms, migraine is broadly classified into two categories, Chronic and Episodic. Migraines can be treated with two types of drugs: abortive and preventive. Abortive medications are especially useful for people who have nausea or vomiting related to their migraine, and they work quickly. Preventive treatment is considered if migraine occurs frequently, typically more than one migraine per week, or if migraine symptoms are severe.

The global migraine market is set to experience favourable growth driven by factors such as increasing female population & increasing cigarette consumption. Further, the scope of growth for this market will be broadened by rising healthcare expenditure and accelerating economic growth. However, growth of this budding market will be hindered by limitations of current migraine therapies, regulatory challenges and high cost associated with migraine drugs.

The report “Global Migraine Market: Industry Analysis & Outlook (2017-2021)” analyses the development of this market, with focus majorly on the U.S. market. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Amgen Inc., Eli Lilly and Company, Teva Pharmaceuticals & Alder Biopharmaceuticals are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global migraine market along with the study of the regional markets.

Table of Content

1. Overview
1.1 Introduction
1.2 Stages
1.3 Diagnosis
1.4 Treatment

2. Global Market Analysis
2.1 Global Migraine Market by Value
2.2 Global Migraine Market Forecast by Value
2.3 Global Migraine Market by Drug Type
2.4 Global Therapeutic Botulinum Toxin Market Forecast by Value
2.5 Global Therapeutic Botulinum Toxin Market by Indication

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/global-migraine-market-industry-analysis-outlook-20172021-report.html/toc

3. Regional Market
3.1 The U.S.
3.1.1 The U.S. Total Migraine Population
3.1.2 The U.S. Diagnosed & Treated Adult Migraine Population
3.1.3 The U.S. Migraine Population with CV Risk Factors
3.1.4 The U.S. Migraine Treatment by Specialty
3.1.5 The U.S. Migraine Treated Population by Drug Type
3.1.6 The U.S. Acute Migraine Prescription Volume
3.2 The U.S Migraine Drugs Revenue
3.2.1 The U.S. Cambia Drug Revenue
3.2.2 The U.S. Lasmiditan Drug Revenue & Treated Patients
3.2.3 The U.S. Alder Drug Revenue
3.3 Europe
3.3.1 Europe Total Migraine and Diagnosed Population
3.4 Europe Migraine Drug Revenue
3.4.1 Europe Alder Drug Revenue

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Growing Female Population
4.1.2 Increasing Cigarette Consumption
4.1.3 Rising HealthCare Expenditure
4.1.4 Accelerating Economic Growth
4.1.5 Increasing Prevalence of Headache Disorder
4.2 Key Trends & Development
4.2.1 Drugs Under Pipeline for Migraine
4.2.2 Technological Advancements
4.2.3 Increasing Awareness for Migraine
4.3 Challenges
4.3.1 Limitations of Current Migraine Therapies
4.3.2 Regulatory Challenges
4.3.3 High Cost Associated

5. Competition
5.1 Global Market
5.1.1 Global Migraine Market- Revenue Comparison of Key Companies
5.1.2 Global Migraine Market- Market Cap Comparison of Key Companies

Continue...

Tuesday, 21 November 2017

Global Migraine Industry Key Trends, Size, Growth, Shares And Forecast Research Report 2016 | Amgen Inc., Teva Pharmaceuticals, Eli Lilly and Company, AstraZeneca

Researchmoz added Most up-to-date research on "Global Migraine Market Report: 2016 Edition" to its huge collection of research reports.

Migraine is a common neurovascular disorder that is characterized by throbbing headaches and is commonly associated with other neurological symptoms, such as nausea, vomiting, and painful sensitivity to lights and sounds. Migraines are thought to result from the activation and sensitization of sensory neurons that have nerve endings in meningeal blood vessels. Migraines can be episodic or chronic. Chronic Migraine (CM) and Episodic Migraine (EM) are both part of the spectrum of migraine disorders, but are distinct clinical entities. The onset of migraine is preceded by certain triggers, which can be unique for each migraine sufferer.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=720347

Triptans and Ergots are among the most common drug options existing in the treatment market for migraine. The global migraine treatment market currently faces several unmet needs and is saturated with the availability of generic drugs. Several branded drugs are under development with safer and more effective profiles, given the vast opportunities existing in the market. The focus of upcoming drugs is to either cure migraine or to reduce the frequency to a level where patients can find tolerable relief.

The migraine market is expected to acquire modest growth driven by launch of new therapies and increasing rate of drug treatment due to increasing female population and rising awareness among physicians and patients. The major growth drivers of the migraine market includes rising spending on medicines, growing female population, increasing cigarette consumption and healthcare expenditure. However, the growth of the market will also remain challenged by complications associated with Triptans, treatment limitations for patients with CV (Cardio Vascular) risk and increased preference for OTC (Over the Counter) medications.

The report, “Global Migraine Market” analyzes the currently prevailing condition of the market along with its future scope of development. The specific market of the U.S. is being discussed in the report. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The major players in the industry are being profiled, along with their key financials and strategies for growth.

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/global-migraine-market-report-2016-edition-report.html/toc

Table of Content

1. Market Overview
1.1 Introduction   
1.2 Types   
1.3 Causes and Pathogenesis   
1.4 Symptoms and Diagnosis   
1.5 Treatment Options

2. Global Migraine Market
2.1 Global Migraine Drug Market by Value   
2.2 Global Migraine Drug Market by Category   
2.3 Global Therapeutic Botulinum Toxin Market by Value   
2.4 Global Therapeutic Botulinum Toxin Market by Indication

3. The U.S. Migraine Market
3.1 The U.S. Total Migraine Population   
3.2 The U.S. Migraine Population by Diagnosis   
3.3 The U.S. Migraine Population with CV Risk Factors   
3.4 The U.S Preventive Migraine Treatment by Specialty   
3.5 The U.S. Acute Migraine Treated Population by Drug Type   
3.6 The U.S. Acute Migraine Prescription Volume   
3.7 The U.S. Migraine Drugs Revenue   
3.7.1 Cambia   
3.7.2 Lasmiditan

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Rising Spending on Medicines   
4.1.2 Growing Female Population   
4.1.3 Increasing Cigarette Consumption   
4.1.4 Rising Healthcare Expenditure
4.2 Trends
4.2.1 Emergence of Peripheral Nerve Stimulators   
4.2.2 Increased Preference for Non Pharmacological Treatment
4.2.3 Higher Prevalence of Migraine than Other Chronic Diseases   
4.2.4 Recurrent Symptoms in Migraine Patients   
4.2.5 Drugs under Development for Migraine
4.3 Challenges
4.3.1 Complications associated with Triptans   
4.3.2 Treatment Limitations for Patients with Cardiovascular Disease   
4.3.3 Rise in Prescription Drugs to OTC Switch

Continue...

Make an Enquiry of this report @
https://www.researchmoz.us/enquiry.php?type=E&repid=720347

Friday, 12 May 2017

Global Migraine Market Key Trends, Size, Growth, Shares And Forecast Research Report 2016

Researchmoz added Most up-to-date research on "Global Migraine Market Report: 2016 Edition" to its huge collection of research reports.

Migraine is a common neurovascular disorder that is characterized by throbbing headaches and is commonly associated with other neurological symptoms, such as nausea, vomiting, and painful sensitivity to lights and sounds. Migraines are thought to result from the activation and sensitization of sensory neurons that have nerve endings in meningeal blood vessels. Migraines can be episodic or chronic. Chronic Migraine (CM) and Episodic Migraine (EM) are both part of the spectrum of migraine disorders, but are distinct clinical entities. The onset of migraine is preceded by certain triggers, which can be unique for each migraine sufferer.

Triptans and Ergots are among the most common drug options existing in the treatment market for migraine. The global migraine treatment market currently faces several unmet needs and is saturated with the availability of generic drugs. Several branded drugs are under development with safer and more effective profiles, given the vast opportunities existing in the market. The focus of upcoming drugs is to either cure migraine or to reduce the frequency to a level where patients can find tolerable relief.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=720347

The migraine market is expected to acquire modest growth driven by launch of new therapies and increasing rate of drug treatment due to increasing female population and rising awareness among physicians and patients. The major growth drivers of the migraine market includes rising spending on medicines, growing female population, increasing cigarette consumption and healthcare expenditure. However, the growth of the market will also remain challenged by complications associated with Triptans, treatment limitations for patients with CV (Cardio Vascular) risk and increased preference for OTC (Over the Counter) medications.

The report, “Global Migraine Market” analyzes the currently prevailing condition of the market along with its future scope of development. The specific market of the U.S. is being discussed in the report. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The major players in the industry are being profiled, along with their key financials and strategies for growth.

Table of Content

1. Market Overview
1.1 Introduction   
1.2 Types   
1.3 Causes and Pathogenesis   
1.4 Symptoms and Diagnosis   
1.5 Treatment Options

2. Global Migraine Market
2.1 Global Migraine Drug Market by Value   
2.2 Global Migraine Drug Market by Category   
2.3 Global Therapeutic Botulinum Toxin Market by Value   
2.4 Global Therapeutic Botulinum Toxin Market by Indication

3. The U.S. Migraine Market
3.1 The U.S. Total Migraine Population   
3.2 The U.S. Migraine Population by Diagnosis   
3.3 The U.S. Migraine Population with CV Risk Factors   
3.4 The U.S Preventive Migraine Treatment by Specialty   
3.5 The U.S. Acute Migraine Treated Population by Drug Type   
3.6 The U.S. Acute Migraine Prescription Volume   
3.7 The U.S. Migraine Drugs Revenue   
3.7.1 Cambia   
3.7.2 Lasmiditan

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Rising Spending on Medicines   
4.1.2 Growing Female Population   
4.1.3 Increasing Cigarette Consumption   
4.1.4 Rising Healthcare Expenditure
4.2 Trends
4.2.1 Emergence of Peripheral Nerve Stimulators   
4.2.2 Increased Preference for Non Pharmacological Treatment
4.2.3 Higher Prevalence of Migraine than Other Chronic Diseases   
4.2.4 Recurrent Symptoms in Migraine Patients   
4.2.5 Drugs under Development for Migraine
4.3 Challenges
4.3.1 Complications associated with Triptans   
4.3.2 Treatment Limitations for Patients with Cardiovascular Disease   
4.3.3 Rise in Prescription Drugs to OTC Switch

5. Competitive Landscape
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=720347

Blood Thawing System Market Insights Shared in Detailed Report

Blood Thawing System Market: Introduction According to the report, the global  blood thawing system market  was valued at ~US$ 174 Mn in 2...